Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.86USD
19 Oct 2018
Change (% chg)

$0.02 (+2.37%)
Prev Close
$0.84
Open
$0.86
Day's High
$0.89
Day's Low
$0.81
Volume
12,309
Avg. Vol
23,924
52-wk High
$3.45
52-wk Low
$0.80

Chart for

About

Cancer Genetics, Inc. is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide... (more)

Overall

Beta: 1.22
Market Cap(Mil.): $53.93
Shares Outstanding(Mil.): 19.79
Dividend: --
Yield (%): --

Financials

  CGIX.OQ Industry Sector
P/E (TTM): -- 28.18 33.65
EPS (TTM): -1.02 -- --
ROI: -57.22 6.89 14.28
ROE: -78.97 10.99 16.00

BRIEF-Cancer Genetics Says Appointed John Roberts As CEO And President

* CANCER GENETICS SAYS ON APRIL 30, BOARD APPOINTED JOHN ROBERTS AS COMPANY'S CEO AND PRESIDENT - SEC FILING Source: (https://bit.ly/2w2ruOW) Further company coverage:

01 May 2018

Competitors

Earnings vs. Estimates